Clinical TrialsSearch results
Number of results: 386
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- SMASH (Steroid Mouthwash for the Prevention of Oral Mucositis in Breast Cancer Chemotherapy) trial
- breast cancer
- Kuba Sayaka
- 2024-07-22
Recruiting
- Single-center prospective study of MA-T oral care product (gel) for xerostomia in Sjogren's syndrome
- Xerostomia
- Takagi Yukinori
- 2025-02-07
Recruiting
- Safety of hypothermic oxygenated machine perfusion in iver transplantation with liver graft from brain-dead donor
- Liver disease indicated for liver transplantation
- Soyama Akihiko
- 2025-03-10
Recruiting
- PROspective study of Treatment with Ensitrelvir for Covid-19 in paTients undergoing HemoDialysis
- COVID-19
- Mukae Hiroshi
- 2024-10-15
Recruiting
- Prospective clinical study of switch to vibegron for overactive bladder patients with inadequate effect of antimuscarinics and mirabegron treatment
- Problem(s) Studied
- Imamura Ryoichi
- 2023-09-29
Recruiting
- Prognostic study of risk stratification among Japanese patients with chronic kidney disease and ischemic heart disease using gated myocardial perfusion SPECT
- Chronic kidney disease, Ischemic heart disease
- Cardiovascular research foundation
- 2009-04-30
Recruiting
- Prevention of Hypoxemia and Hypercarbonemia by High Flow Nasal Cannula Respiratory Management during Fiber Intubation in Patients with Difficult Intubation
- Oral Maxillo Facial Surgery
- Kurata Shinji
- 2025-02-10
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07
Recruiting
- Phase II study of IRInotecan after COmbined immunotherapy for extensive-disease small cell lung cancer
- Extensive-disease small cell lung cancer
- Mukae Hiroshi
- 2021-11-04